235 related articles for article (PubMed ID: 15467302)
1. Effects of eplerenone, a selective aldosterone blocker, on the progression of left ventricular dysfunction and remodeling in rats with dilated cardiomyopathy.
Wahed MI; Watanabe K; Ma M; Yamaguchi K; Takahashi T; Tachikawa H; Kodama M; Aizawa Y
Pharmacology; 2005 Feb; 73(2):81-8. PubMed ID: 15467302
[TBL] [Abstract][Full Text] [Related]
2. Effects of pranidipine, a novel calcium channel antagonist, on the progression of left ventricular dysfunction and remodeling in rats with heart failure.
Wahed MI; Watanabe K; Ma M; Nakazawa M; Takahashi T; Hasegawa G; Naito M; Yamamoto T; Kodama M; Aizawa Y
Pharmacology; 2004 Sep; 72(1):26-32. PubMed ID: 15292652
[TBL] [Abstract][Full Text] [Related]
3. Additive improvement of left ventricular remodeling and neurohormonal activation by aldosterone receptor blockade with eplerenone and ACE inhibition in rats with myocardial infarction.
Fraccarollo D; Galuppo P; Hildemann S; Christ M; Ertl G; Bauersachs J
J Am Coll Cardiol; 2003 Nov; 42(9):1666-73. PubMed ID: 14607457
[TBL] [Abstract][Full Text] [Related]
4. Effects of eplerenone on transcriptional factors and mRNA expression related to cardiac remodelling after myocardial infarction.
Enomoto S; Yoshiyama M; Omura T; Matsumoto R; Kusuyama T; Kim S; Izumi Y; Akioka K; Iwao H; Takeuchi K; Yoshikawa J
Heart; 2005 Dec; 91(12):1595-600. PubMed ID: 15797934
[TBL] [Abstract][Full Text] [Related]
5. Effects of long-term monotherapy with eplerenone, a novel aldosterone blocker, on progression of left ventricular dysfunction and remodeling in dogs with heart failure.
Suzuki G; Morita H; Mishima T; Sharov VG; Todor A; Tanhehco EJ; Rudolph AE; McMahon EG; Goldstein S; Sabbah HN
Circulation; 2002 Dec; 106(23):2967-72. PubMed ID: 12460880
[TBL] [Abstract][Full Text] [Related]
6. Low dose carvedilol inhibits progression of heart failure in rats with dilated cardiomyopathy.
Watanabe K; Ohta Y; Nakazawa M; Higuchi H; Hasegawa G; Naito M; Fuse K; Ito M; Hirono S; Tanabe N; Hanawa H; Kato K; Kodama M; Aizawa Y
Br J Pharmacol; 2000 Aug; 130(7):1489-95. PubMed ID: 10928949
[TBL] [Abstract][Full Text] [Related]
7. Telmisartan, an angiotensin-II receptor blocker ameliorates cardiac remodeling in rats with dilated cardiomyopathy.
Sukumaran V; Watanabe K; Veeraveedu PT; Thandavarayan RA; Gurusamy N; Ma M; Yamaguchi K; Suzuki K; Kodama M; Aizawa Y
Hypertens Res; 2010 Jul; 33(7):695-702. PubMed ID: 20535115
[TBL] [Abstract][Full Text] [Related]
8. [Additive improvement of left ventricular remodeling by aldosterone receptor blockade with eplerenone and angiotensin II type 1 receptor antagonist in rats with myocardial infarction].
Yoshiyama M; Omura T; Yoshikawa J
Nihon Yakurigaku Zasshi; 2004 Aug; 124(2):83-9. PubMed ID: 15277726
[TBL] [Abstract][Full Text] [Related]
9. Spironolactone alleviates late cardiac remodeling after left ventricular restoration surgery.
Tsukashita M; Marui A; Nishina T; Yoshikawa E; Kanemitsu H; Wang J; Ikeda T; Komeda M
J Thorac Cardiovasc Surg; 2008 Jul; 136(1):58-64. PubMed ID: 18603054
[TBL] [Abstract][Full Text] [Related]
10. Effects of eplerenone and salt intake on left ventricular remodeling after myocardial infarction in rats.
Urabe A; Izumi T; Abe Y; Taniguchi I; Mochizuki S
Hypertens Res; 2006 Aug; 29(8):627-34. PubMed ID: 17137219
[TBL] [Abstract][Full Text] [Related]
11. The specific mineralocorticoid receptor blocker eplerenone attenuates left ventricular remodeling in mice lacking the gene encoding guanylyl cyclase-A.
Zhang Q; Saito Y; Naya N; Imagawa K; Somekawa S; Kawata H; Takeda Y; Uemura S; Kishimoto I; Nakao K
Hypertens Res; 2008 Jun; 31(6):1251-6. PubMed ID: 18716375
[TBL] [Abstract][Full Text] [Related]
12. Comparative effects of perindopril with enalapril in rats with dilated cardiomyopathy.
Watanabe K; Saito Y; Ma M; Wahed M; Abe Y; Hirabayashi K; Narasimman G; Wen J; Suresh P; Ali F; Shirai K; Soga M; Nagai Y; Nakazawa M; Hasegawa G; Naito M; Tachikawa H; Kodama M; Aizawa Y; Yamaguchi K; Takahashi T
J Cardiovasc Pharmacol; 2003 Dec; 42 Suppl 1():S105-9. PubMed ID: 14871039
[TBL] [Abstract][Full Text] [Related]
13. Randomized, double-blind, multicenter, placebo-controlled study evaluating the effect of aldosterone antagonism with eplerenone on ventricular remodeling in patients with mild-to-moderate heart failure and left ventricular systolic dysfunction.
Udelson JE; Feldman AM; Greenberg B; Pitt B; Mukherjee R; Solomon HA; Konstam MA
Circ Heart Fail; 2010 May; 3(3):347-53. PubMed ID: 20299607
[TBL] [Abstract][Full Text] [Related]
14. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.
Pitt B; Remme W; Zannad F; Neaton J; Martinez F; Roniker B; Bittman R; Hurley S; Kleiman J; Gatlin M;
N Engl J Med; 2003 Apr; 348(14):1309-21. PubMed ID: 12668699
[TBL] [Abstract][Full Text] [Related]
15. Blocking aldosterone in heart failure.
Shafiq MM; Miller AB
Ther Adv Cardiovasc Dis; 2009 Oct; 3(5):379-85. PubMed ID: 19661156
[TBL] [Abstract][Full Text] [Related]
16. Amiodarone improves cardiac sympathetic nerve function to hold norepinephrine in the heart, prevents left ventricular remodeling, and improves cardiac function in rat dilated cardiomyopathy.
Tachikawa H; Kodama M; Watanabe K; Takahashi T; Ma M; Kashimura T; Ito M; Hirono S; Okura Y; Kato K; Hanawa H; Aizawa Y
Circulation; 2005 Feb; 111(7):894-9. PubMed ID: 15710769
[TBL] [Abstract][Full Text] [Related]
17. Spironolactone modulates expressions of cardiac mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase 2 and prevents ventricular remodeling in post-infarct rat hearts.
Takeda M; Tatsumi T; Matsunaga S; Hayashi H; Kimata M; Honsho S; Nishikawa S; Mano A; Shiraishi J; Yamada H; Takahashi T; Matoba S; Kobara M; Matsubara H
Hypertens Res; 2007 May; 30(5):427-37. PubMed ID: 17587755
[TBL] [Abstract][Full Text] [Related]
18. Quinapril inhibits progression of heart failure and fibrosis in rats with dilated cardiomyopathy after myocarditis.
Juan W; Nakazawa M; Watanabe K; Ma M; Wahed MI; Hasegawa G; Naito M; Yamamoto T; Fuse K; Kato K; Kodama M; Aizawa Y
Mol Cell Biochem; 2003 Sep; 251(1-2):77-82. PubMed ID: 14575307
[TBL] [Abstract][Full Text] [Related]
19. Do diuretics and aldosterone receptor antagonists improve ventricular remodeling?
Pitt B
J Card Fail; 2002 Dec; 8(6 Suppl):S491-3. PubMed ID: 12555163
[TBL] [Abstract][Full Text] [Related]
20. Effects of angiotensin-II receptor blocker candesartan cilexetil in rats with dilated cardiomyopathy.
Shirai K; Watanabe K; Ma M; Wahed MI; Inoue M; Saito Y; Suresh PS; Kashimura T; Tachikawa H; Kodama M; Aizawa Y
Mol Cell Biochem; 2005 Jan; 269(1-2):137-42. PubMed ID: 15786726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
